MMI to expand study of robotic microsurgery for Alzheimer's

The FDA has authorized MMI to enroll more patients in a feasibility trial studying the Symani robot for microsurgery to restore drainage paths in lymph nodes of Alzheimer's patients. The expansion allows the company to advance clinical evidence for the technology.